Evidence map›Paper›PMID 31391389›Full record

ArticleInternal medicine (Tokyo, Japan)2019

Vascular Ehlers-Danlos Syndrome with a Novel Missense Mutation in COL3A1: A Man in His 50s with Aortic Dissection after Interventional Treatment for Hemothorax as the First Manifestation.

Kosuke Sakai, Maiko Toda, Hiroyuki Kyoyama, Hiroaki Nishimura, Akitoshi Kojima, Yoshiki Kuwabara, Yumiko Kobayashi, Satoshi Kikuchi, Yusuke Hirata, Gaku Moriyama and 6 more

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. PulmonaryRespiratory medicine case reports · 2024
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Kosuke SakaiDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Maiko TodaDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Hiroyuki KyoyamaDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Hiroaki NishimuraDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Akitoshi KojimaDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Yoshiki KuwabaraDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Yumiko KobayashiDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Satoshi KikuchiDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Yusuke HirataDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Gaku MoriyamaDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Wataru WatanabeDepartment of Diagnostic Imaging, Saitama Medical Center, Saitama Medical University, Japan.
Koichi AkutsuDepartment of Cardiovascular Medicine, Nippon Medical School, Japan.
Maki NakaiDivision of Personalized Genetic Medicine, Nippon Medical School Hospital, Japan.
Takeshi YamadaDivision of Personalized Genetic Medicine, Nippon Medical School Hospital, Japan.
Akihiko GemmaDepartment of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, Japan.
Kazutsugu UematsuDepartment of Pulmonary Medicine, Saitama Medical Center, Saitama Medical University, Japan.
Social Insurance Saitama Chuo Hospital · JPSaitama Medical University · JPNippon Medical School · JPNippon Medical School Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type III collagen is the major protein in the walls of blood vessels and hollow organs; it is decreased in patients with vascular Ehlers-Danlos syndrome (EDS). A 52-year-old man was admitted for severe back pain, and right hemothorax was suspected by chest computed tomography. Immediately after embolization for bleeding bronchial artery, aortic dissection occurred and was treated conservatively in the intensive-care unit. Vascular EDS with a mutation of COL3A1 cDNA (c.3175G>A) was diagnosed. When vascular EDS is suspected, the patient should be treated prophylactically, and a genetic examination should be performed to confirm the diagnosis.

Indexed as

Aortic DissectionCollagen Type IIIEhlers-Danlos SyndromeEmbolization, TherapeuticGenetic TestingHemorrhageHemothoraxHumansMaleMiddle AgedMutation, MissenseTomography, X-Ray ComputedCOL3A1 protein, humanCollagen Type IIIangiographyaortic dissectionCOL3A1hemothoraxvascular Ehlers-Danlos syndrome

Identifiers

PMID31391389
PMCPMC6928492
OpenAlexW2964745057

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.